🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. PYTEST® 14C-Urea Breath Test

    Phathom Pharmaceuticals

    H Pylori Infection

    approved small molecule active

    1 trial

  2. PYTEST® 14C-Urea Capsule Breath Test (at Home)

    Phathom Pharmaceuticals

    H. Pylori Infection

    approved small molecule active

    1 trial

  3. Pacemaker Medtronic EnRhythm

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial

  4. Pantoprazole Teva 40 mg maagsapresistente tabletten, Mycophenolate mofetil Sandoz 500 mg Film-coated Tablets, Mycophenolate Mofetil Accord 500 mg plėvele dengtos tabletės, CellCept 500 mg film-coated tablets

    Disc Medicine

    Post Transplantation Patients

    approved small molecule active

    1 trial

  5. Paracetamol Biofarm, 500 mg, tabletki, Placebo - Nalgesin forte, Nalgesin Forte, 550 mg, tabletki powlekane

    Novo Nordisk A/S

    Knee osteoarthritis

    approved small molecule active

    1 trial

  6. Pegvaliase

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria

    approved mab active

    1 trial

  7. Pegylated Interferon

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  8. Pentocur 1 g pulver till injektionsvätska, lösning

    The George Institute

    Major depressive disorder

    approved small molecule active

    1 trial

  9. Perineural infusion [continuous peripheral nerve block(s)]

    United Therapeutics Europe Ltd

    Phantom Limb Pain

    approved small molecule completed

    1 trial

  10. Pfizer-BioNTech mRNA COVID-19 vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    COVID -19

    approved small molecule active

    1 trial

  11. Pharmacist Practice Change to Dispense Appropriate Opioid Quantities for Acute Pain

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use

    approved small molecule completed

    1 trial

  12. Pharmacotherapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule completed

    1 trial

  13. Pharmacotherapy for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved small molecule completed

    1 trial

  14. Pidotimod

    Almirall, S.A.

    Recurrent Respiratory Tract Infections

    approved small molecule completed

    1 trial

  15. Pioglitazone

    Takeda

    Type II Diabetes Mellitus

    approved small molecule completed

    1 trial

  16. Pioglitazone

    Takeda

    Obesity

    approved small molecule completed

    1 trial

  17. Pioglitazone

    Takeda

    Metabolic Syndrome

    approved small molecule completed

    1 trial

  18. Pioglitazone

    Takeda

    Nonalcoholic Steatohepatitis

    approved small molecule completed

    1 trial

  19. Pioglitazone

    Takeda

    Bone Metabolism

    approved small molecule completed

    1 trial

  20. Pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials

  21. Pioglitazone

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    9 trials

  22. Pioglitazone

    Takeda

    Diabetes Type 2

    approved small molecule completed

    1 trial

  23. Pioglitazone 15mg

    Takeda

    Inflammation

    approved small molecule completed

    1 trial

  24. Pioglitazone 15mg

    United Therapeutics Europe Ltd

    High Altitude

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources